Gemcitabine monotherapy in patients with heavily treated nasopharyngeal cancer: a case series

ConclusionOur findings suggest that GEM monotherapy is well tolerated and has potential as an active agent in Japanese patients with recurrent/metastatic NPC who have been heavily pretreated.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research